Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Sequent Scientific Ltd - 512529 - Closure of Trading Window

 Notice is hereby given that pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read with Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for all Connected Persons/Designated Persons and their immediate relatives to deal in the securities of the Company shall remain closed from Thursday, July 01, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending on June 30, 2021. The date of Meeting of the Board of Directors of the Company at which the aforesaid Financial Results are to be approved, will be intimated to the Stock Exchanges in due course. This is for your information and appropriate dissemination.
30-06-2021
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed Annual Secretarial Compliance Report of Sequent Scientific Limited issued by M/s. Nilesh Shah & Associates, Practicing Company Secretaries, for the year ended March 31, 2021. Kindly take the above on records.
30-06-2021
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has, as part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Thursday, July 01, 2021 to discuss its 4QF21 & FY21 financial results. The Conference call details are enclosed.
29-06-2021
Bigul

Sequent Scientific Ltd - 512529 - Corporate Action-Board to consider Dividend

 Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Meeting of the Board of Directors of SeQuent Scientific Limited ('the Company') is scheduled to be held on Wednesday, June 30, 2021 to consider and approve, inter-alia: a)the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2021. b)recommendation of dividend, if any, for the financial year ended March 31, 2021. Kindly take the above on records.
24-06-2021
Bigul

Sequent Scientific Ltd - 512529 - Board to consider FY21 results & Dividend on June 30, 2021

 Sequent Scientific Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on June 30, 2021, inter alia, to consider and approve:1. The Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2021.2. recommendation of dividend, if any, for the financial year ended March 31, 2021.
24-06-2021
Bigul

Sequent Scientific Ltd - 512529 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Meeting of the Board of Directors of SeQuent Scientific Limited ('the Company') is scheduled to be held on Wednesday, June 30, 2021 to consider and approve, inter-alia: a)the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2021. b)recommendation of dividend, if any, for the financial year ended March 31, 2021. Kindly take the above on records.
24-06-2021
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Credit Rating

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we hereby inform you that India Ratings and Research has upgraded the Company's Long-Term Issuer Rating to 'IND A+' from 'IND A' with outlook being 'Positive'. We request you to take the same on your record.
16-06-2021

Reclusive Mankekar makes a splash with Solara stake

 The Mumbai-based reclusive investor held nearly 4 per cent stake in Sequent Scientific till March 2018 and about 2.07 per cent in Strides Pharma till September 2017. This is Mankekar's first major investment since September 2019. Shareholding data showed he has not owned over 1 per cent in any company since then.
12-05-2021
Bigul

Sequent Scientific (280.3): Buy

 Investors with a short-term perspective can buy the stock of Sequent Scientific at current levels. Since the stock took support at around 50 in March
26-04-2021
Bigul

SEQUENT SCIENTIFIC LTD. - 512529 - Non-Applicability Of SEBI Circular-SEBI/HO/DDHS/ CIR/P/2018/144 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities

 This is with reference to the SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, in respect of fund raising by issuance of Debt Securities by Large Entities, we would like to confirm that for the financial year ended March 31, 2021, our Company is 'Not a Large Corporate' as per the framework provided in the aforesaid Circular. Kindly take the same on your record.
19-04-2021
Next Page
Close

Let's Open Free Demat Account